Medico Remedies Ltd
Medico Remedies Ltd (MEDICO) last reported results for the quarter ended Jun 2026, with sales of ₹69.4 crore and net profit of ₹2.52 crore. The stock last traded at ₹21.8, a market capitalisation of ₹181 crore, on a P/E of 13.1. Over the past 52 weeks the stock has ranged between ₹20.5 and ₹57. Figures are as of 6 Oct 2026 and are not real time.
Medico Remedies Ltd share price and key metrics
- Current price
- ₹21.8
- Market cap
- ₹181 cr
- Stock P/E
- 13.1
- Book value
- ₹9.1
- ROE
- 19.0%
- ROCE
- 23.3%
- Dividend yield
- 0.00%
- 52w high / low
- 57.0/20.5
Metrics as of 6 Oct 2026. Not real time.
Track Medico Remedies Ltd
Cruxal reads every Medico Remedies Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Medico Remedies Ltd growth and returns
- 10 Years
- 12%
- 5 Years
- 11%
- 3 Years
- 14%
- TTM
- 50%
- 10 Years
- 28%
- 5 Years
- 38%
- 3 Years
- 22%
- TTM
- 34%
- 10 Years
- %
- 5 Years
- 6%
- 3 Years
- -33%
- 1 Year
- -56%
- 10 Years
- 14%
- 5 Years
- 17%
- 3 Years
- 18%
- Last Year
- 19%
Medico Remedies Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹69.4 cr, up 81.4% from ₹38.25 cr a year earlier. Net profit was ₹2.52 cr, up 38.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 39.35 | 39.49 | 41.3 | 38.25 | 52.64 | 58.68 | 56.81 | 69.4 |
| Expenses | 36.94 | 36.38 | 34.64 | 35.43 | 49.91 | 54.35 | 49.66 | 66.1 |
| Operating profit | 2.41 | 3.11 | 6.66 | 2.82 | 2.73 | 4.33 | 7.15 | 3.3 |
| OPM % | 6.12% | 7.88% | 16.13% | 7.37% | 5.19% | 7.38% | 12.59% | 4.76% |
| Other income | 0.68 | 1.43 | 0.29 | 0.66 | 1.72 | 0.68 | 2.87 | 1.17 |
| Interest | 0.21 | 0.28 | 0.49 | 0.28 | 0.24 | 0.39 | 0.9 | 0.41 |
| Depreciation | 0.75 | 0.76 | 0.77 | 0.77 | 0.73 | 0.79 | 0.8 | 0.72 |
| Profit before tax | 2.13 | 3.5 | 5.69 | 2.43 | 3.48 | 3.83 | 8.32 | 3.34 |
| Tax % | 27.23% | 25.14% | 23.90% | 25.51% | 25.86% | 25.07% | 29.69% | 24.55% |
| Net profit | 1.55 | 2.62 | 4.34 | 1.82 | 2.57 | 2.87 | 5.86 | 2.52 |
| EPS (₹) | 0.19 | 0.32 | 0.52 | 0.22 | 0.31 | 0.35 | 0.71 | 0.30 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Medico Remedies Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54 | 61 | 98 | 89 | 122 | 121 | 140 | 145 | 151 | 206 | 238 |
| Operating profit | 4 | 3 | 3 | 3 | 5 | 7 | 10 | 13 | 15 | 17 | 18 |
| OPM % | 7% | 6% | 2.8% | 3.2% | 4.3% | 6% | 7% | 9% | 10% | 8% | 7% |
| Net profit | 2 | 1 | 2 | 2 | 3 | 5 | 7 | 8 | 10 | 13 | 14 |
| EPS (₹) | 0.25 | 0.15 | 0.19 | 0.20 | 0.31 | 0.58 | 0.87 | 1.00 | 1.22 | 1.58 | 1.67 |
TTM is the trailing twelve months to the most recent quarter.
Medico Remedies Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 3 | 4 | 4 | 4 | 4 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 13 | 23 | 24 | 26 | 28 | 20 | 27 | 36 | 46 | 59 |
| Borrowings | 19 | 13 | 14 | 14 | 15 | 13 | 10 | 8 | 14 | 19 |
| Other liabilities | 13 | 20 | 35 | 32 | 28 | 28 | 34 | 36 | 43 | 59 |
| Total liabilities | 48 | 59 | 76 | 75 | 76 | 77 | 87 | 96 | 120 | 153 |
| Fixed assets | 7 | 7 | 12 | 13 | 15 | 18 | 22 | 21 | 21 | 20 |
| CWIP | 3 | 4 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 3 |
| Investments | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 |
| Other assets | 39 | 48 | 63 | 60 | 59 | 59 | 64 | 73 | 96 | 129 |
| Total assets | 48 | 59 | 76 | 75 | 76 | 77 | 87 | 96 | 120 | 153 |
As reported by the company. Total assets equal total liabilities by construction.
Medico Remedies Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3 | 5 | 5 | 1 | -11 | 6 | 8 | 2 | 5 | 6 |
| Cash from investing | -3 | -5 | -4 | -3 | -17 | -2 | -7 | -3 | -3 | -5 |
| Cash from financing | 6 | -1 | -1 | 3 | 18 | -6 | -2 | -0 | -1 | -1 |
| Net cash flow | -0 | -0 | -0 | 0 | -10 | -2 | -0 | -1 | 1 | 1 |
| Free cash flow | -4 | 3 | 1 | -2 | -28 | 3 | 2 | -0 | 2 | 1 |
| CFO / operating profit | -68% | 162% | 198% | 53% | -198% | 104% | 111% | 43% | 58% | 64% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Medico Remedies Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 10% | 9% | 8% | 8% | 10% | 15% | 21% | 21% | 21% | 23% |
| Debtor days | 122 | 102 | 109 | 98 | 82 | 92 | 94 | 125 | 138 | 145 |
| Inventory days | 96 | 125 | 74 | 99 | 58 | 76 | 69 | 54 | 90 | 72 |
| Days payable | 112 | 147 | 149 | 143 | 100 | 113 | 108 | 105 | 117 | 119 |
| Cash conversion cycle | 105 | 80 | 33 | 54 | 39 | 54 | 54 | 75 | 111 | 98 |
| Working capital days | 110 | 88 | 49 | 61 | 50 | 52 | 54 | 74 | 90 | 84 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Medico Remedies Ltd shareholding pattern
Promoters held 61.38% at Jun 2026, down from 62.59% at Jun 2025. FIIs 0.08% and DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 73.34% | 66.83% | 63.79% | 62.59% | 61.38% | 61.38% | 61.38% | 61.38% |
| FIIs | 0.22% | 0.39% | 0.11% | 0.07% | 0.30% | 0.49% | 0.03% | 0.08% |
| DIIs | 0.97% | 0.78% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| Public | 25.47% | 32.00% | 36.08% | 37.33% | 38.30% | 38.13% | 38.60% | 38.55% |
| No. of shareholders | 12,887 | 14,104 | 15,424 | 16,474 | 18,503 | 16,562 | 16,189 | 15,863 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Medico Remedies Ltd corporate filings
- Medico Remedies clarifies recent price movement; no new financial or operational disclosures providedCompany Updatelow impact
Cruxal's analysis: The company, with a market cap of approximately 181 crore and current stock price of…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: Please find enclosed, Intimation for Closure of Trading Window
Read the full analysis - Medico Remedies Limited announces successful conclusion of 32nd Annual General Meeting and approval of key management resolutionsAGM/EGMlow impact
Cruxal's analysis: Medico Remedies Limited has successfully concluded its 32nd Annual General Meeting held…
Read the full analysis - Medico Remedies Limited concludes 32nd Annual General Meeting; focuses on operational outlook and leadership continuityAGM/EGMlow impact
Cruxal's analysis: Medico Remedies Limited has successfully concluded its 32nd Annual General Meeting held…
Read the full analysis - Medico Remedies Ltd files Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Medico Remedies Ltd has submitted its Annual Report for the financial year 2025-26 in…
Read the full analysis - Medico Remedies Ltd announces book closure for corporate actionCorp. Actionlow impact
Cruxal's analysis: Medico Remedies Ltd has issued an intimation regarding the book closure date in…
Read the full analysis - Medico Remedies Limited Announces 32nd AGM and Re-appointment of Key Managerial PersonnelAGM/EGMmedium impact
Cruxal's analysis: Medico Remedies Limited has scheduled its 32nd Annual General Meeting for September 22…
Read the full analysis - Medico Remedies Ltd issues clarification regarding recent stock price movementCompany Updatelow impact
Cruxal's analysis: The company has issued a formal clarification in response to recent fluctuations in its…
Read the full analysis - Medico Remedies Q1 FY27 Results: Revenue Grows 81% YoY, Profit Rises 66% YoY; Board Approves Key Re-appointmentsResulthigh impact
Cruxal's analysis: Medico Remedies Limited reported strong Q1 FY27 performance with revenue from operations…
Read the full analysis - Medico Remedies Limited schedules Board Meeting for June 2026 quarterly resultsBoard Meetinglow impact
Cruxal's analysis: Medico Remedies Limited has issued a formal notice for a Board of Directors meeting…
Read the full analysis - Medico Remedies secures international government supply order worth INR 13.38 croreCompany Updatehigh impact
Cruxal's analysis: Medico Remedies Limited has secured a government supply order from PROMESE/CAL, Dominican…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.